Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Vinci Capital is a leading Swiss private equity firm with over MCHF 200 under management. Since 1998 they have provided equity to over 30 Swiss technology and industrial companies to finance innovation, growth and succession-buyouts. Their investment team capitalizes on 40 years of cumulated experience in private equity and a solid operational background in growth, turn-around, consolidation, IPOs and M&a;A situations.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2004 | immatics biotechnologies | Series A | 0 |
2/2010 | SolvAxis | Venture Round | 0 |
10/2005 | Kuros Biosciences | Post-IPO Equity | 0 |
1/2005 | Kuros Biosciences | Post-IPO Equity | 0 |
10/2012 | SENSIMED | Series C | 0 |
2/2014 | Anergis | Series A | 8.9M |
12/2007 | SENSIMED | Series A | 6.9M |
7/2009 | Symetis | Series B | 0 |
11/2006 | Datamars | Venture Round | 8.9M |
4/2014 | Beqom | Convertible Note | 10.6M |
9/2008 | Omnisens SA | Venture Round | 5.3M |
10/2009 | Evolva | Series B | 27.8M |
5/2004 | Addex Therapeutics | Series B | 0 |
12/2009 | Evolva | Post-IPO Equity | 27.5M |
3/2011 | Anergis | Series A | 20M |
4/2014 | Beqom | Convertible Note | 0 |
2/2014 | Anergis | Series A | 0 |
10/2012 | SENSIMED | Series C | 0 |
3/2011 | Anergis | Series A | 0 |
2/2010 | SolvAxis | Venture Round | 0 |
12/2009 | Evolva | Post-IPO Equity | 0 |
10/2009 | Evolva | Series B | 0 |
7/2009 | Symetis | Series B | 0 |
9/2008 | Omnisens SA | Venture Round | 0 |
12/2007 | SENSIMED | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|